Tests:Coagulation Screen: Difference between revisions
Tests:Coagulation Screen
No edit summary |
m Mark as reviewed |
||
| (13 intermediate revisions by 3 users not shown) | |||
| Line 3: | Line 3: | ||
[[Category:Tests]] | [[Category:Tests]] | ||
[[Category:Haematology]] | [[Category:Haematology]] | ||
[[Category:Hawera]] | |||
{| class="wikitable" | {| class="wikitable" | ||
! colspan="2" | | ! colspan="2" | | ||
| Line 35: | Line 36: | ||
Fibrinogen (FIB) | Fibrinogen (FIB) | ||
|- | |- | ||
|Availability | |Base Lab Availability | ||
|Monday - Sunday, testing routinely available out of hours | |Monday - Sunday, testing routinely available out of hours | ||
|- | |||
|Hawera Lab Availability | |||
|Monday - Friday, 8 am to 4 30pm | |||
|- | |- | ||
|Turnaround Time | |Turnaround Time | ||
|0.5-4 | |0.5 -4 hours | ||
|- | |- | ||
|Stability – Add test | |Stability – Add test | ||
| Line 61: | Line 65: | ||
|Clotted | |Clotted | ||
Over or under filled | Over or under filled | ||
Grossly haemolysed | Grossly haemolysed | ||
Sample older than 24 hours - 12 hours for APTT | Sample older than 24 hours - 12 hours for APTT | ||
|- | |- | ||
| Line 91: | Line 97: | ||
|Includes Prothrombin ratio, APTT, FIB and TCT. | |Includes Prothrombin ratio, APTT, FIB and TCT. | ||
{| class="wikitable" | {| class="wikitable" | ||
|PR | |INR/PR | ||
|0.8-1.2 ratio | |0.8-1.2 ratio | ||
|- | |- | ||
| Line 105: | Line 111: | ||
|- | |- | ||
|Test Method | |Test Method | ||
|Mechanical clot detection performed on Stago Compact | |Mechanical clot detection performed on Stago Compact Max³ Analyser | ||
|- | |- | ||
|Advanced Notice | |Advanced Notice | ||
| Line 116: | Line 122: | ||
== Comments == | == Comments == | ||
|- | |- | ||
| colspan="2" |Please indicate if patient is | | colspan="2" |Please indicate on the request form if patient is prescribed anticoagulants. This includes, but is not limited to Warfarin, unfractionated heparin, Dabigatran, and Rivaroxaban. | ||
This includes, but is not limited to Warfarin, unfractionated heparin, Dabigatran, and Rivaroxaban. | |||
|} | |} | ||
{{DocMeta | |||
| owner = Mabbett1 | |||
| review_ping = | |||
}} | |||
<!-- review-ping: 2026-10-03T02:58:39.314Z --> | |||